Globally, a staggering 2.2 billion individuals suffer from either near or distance vision impairment, of which at least 1 billion cases could have been prevented or remain unaddressed. The predominant causes of such vision impairment at a global scale are refractive errors and cataracts. It is noteworthy that only 36% of individuals with distance vision impairment due to refractive errors and a mere 17% with vision impairment due to cataracts have gained access to suitable interventions. The escalating prevalence of eye diseases underscores the necessity for advanced AI algorithms capable of analyzing intricate image data beyond the reach of conventional methods. For example, the complex nature of retinal imagery necessitates the use of Convolutional Neural Networks (CNNs), which rely on convolution operations for feature extraction. Networks such as ResNet-50, InceptionV3, and EfficientNetB3 exemplify such architectures. In this study, EfficientNetB3, with a 30-epoch training cycle, demonstrated superior performance in retinal disease classification, achieving training and testing accuracies of 99.9% and 96%, respectively. While these findings attest to the potential of using CNNs, particularly EfficientNetB3, for diagnosing retinal diseases, additional research is essential for validating these results across diverse populations and healthcare environments. The integration of these models into telemedicine platforms holds promise for alleviating healthcare system burdens and enhancing patient outcomes.